- Home
- NBP vs ANGO Comparison
NBP vs ANGO Comparison
Compare NBP & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NBP | ANGO |
|---|---|---|
| Founded | 2014 | 1988 |
| Country | United States | United States |
| Employees | 32 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 379.3M | 439.8M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | NBP | ANGO |
|---|---|---|
| Price | $2.64 | $11.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $9.00 | ★ $19.33 |
| AVG Volume (30 Days) | ★ 806.7K | 252.4K |
| Earning Date | 05-14-2026 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.92 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $291,010,000.00 |
| Revenue This Year | N/A | $9.11 |
| Revenue Next Year | N/A | $4.94 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $2.44 | $8.36 |
| 52 Week High | $5.19 | $13.99 |
Technical Indicators
Market Signals| Indicator | NBP | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 38.23 | 57.06 |
| Support Level | N/A | $10.40 |
| Resistance Level | $3.80 | $11.74 |
| Average True Range (ATR) | 0.24 | 0.36 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 18.97 | 91.92 |
Price Performance
Historical ComparisonAbout NBP NovaBridge Biosciences American Depositary Shares
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. It integrates scientific discovery with strategic planning and project management to move therapies from research toward potential patient use. Its pipeline includes Givastomig, VIS-101, Ragistomig and Uliledlimab.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.